Guinea-Bissau hepatitis B vaccine shortage leaves 7,000 infants unprotected

A funding shortfall—reportedly tied to a costly essay—has disrupted hepatitis B vaccine supply in Guinea-Bissau, leaving an estimated 7,000 newborns without immunization. The claim is emerging and lacks corroboration; the underlying cause and exact scope remain uncertain. This matters because it signals a potential public-health setback in a low-income country with high hepatitis B burden.